The 2024 ACR Awards of Distinction honor members for their outstanding contributions to the field of rheumatology.
Don’t Be Afraid to Engage: Health Technologies for Patients & Rheumatologists
Symptom checkers, telehealth and more—here are insights into the effects new technologies are having on rheumatology.
A World View: The ACR Global Research Exchange Program Promotes Mentorship & Long-Term Collaboration in Rheumatology
2023 marks the post-pandemic return of research exchanges hosted by the ACR & EULAR to benefit junior academic rheumatologists & rheumatology professionals.
Beyond the Rheumatologist: Interprofessional Alliances Are Crucial to Rheumatic Care
How can we ensure patients are receiving care that addresses all of the ways rheumatic disease affects their life? In this ACR Convergence 2023 session, experts discuss the value of a strong interprofessional care team.
The Emotional Toll of Rheumatic Disease
Expressing empathy, engaging patients in conversations about their emotional health and having an overall understanding of grief can help rheumatology health professionals better care for their patients. During a session at ACR Convergence 2023, mental health professionals and patients highlighted how grief affects patients with rheumatic disease and how providers can respond.
Going Viral: How to Find & Engage Your Audience to Become a Podcast Celebrity
A panel of experts, including ACR on Air Host Jonathan Hausmann, MD, provided tips and insights into creating a podcast and engaging with an audience.
Advice for Authors: Editors Provide Tips & Tricks for Getting Your Work Published
Researchers and physician-scientists often need practical advice for getting their work published. Here are insights into how to select an appropriate publication, manage co-author relationships and more from a panel of experts in both rheumatology and publishing.
Pharmacokinetic Modeling & Efficacy Extrapolation: FDA Takes New Approaches to Drug Approvals
An array of new and expanded indications of therapeutics for rheumatic disease last year relied on pharmacokinetic modeling for intravenous dosing and efficacy extrapolation for pediatric populations.
Pregnancy Outcomes in Patients Treated with TNF Inhibitors
A study found the continuation of tumor necrosis factor inhibitor (TNFi) treatment in patients with chronic rheumatic inflammatory diseases after pregnancy diagnosis was not associated with worse outcomes than those who discontinued treatment with TNFi’s.
Old Disease, New Tricks: A Novel Approach to Understanding Gout
SAN DIEGO—Gout has sometimes been called the disease of kings, not only because of the fact that purine-rich foods were long affordable only to wealthier individuals, but also because the disease has been around since the monarchies that existed centuries ago. However, with groundbreaking research leading to a better understanding of gout, we can now…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 7
- Next Page »